Rossmax International Ltd. (TPEX:4121)
14.95
-0.10 (-0.66%)
Aug 11, 2025, 1:30 PM CST
Accolade Revenue
Rossmax International had revenue of 981.80M TWD in the quarter ending June 30, 2025, with 2.64% growth. This brings the company's revenue in the last twelve months to 3.85B, up 1.29% year-over-year. In the year 2024, Rossmax International had annual revenue of 3.85B with 1.11% growth.
Revenue (ttm)
3.85B
Revenue Growth
+1.29%
P/S Ratio
0.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.85B | 42.10M | 1.11% |
Dec 31, 2023 | 3.81B | -535.69M | -12.33% |
Dec 31, 2022 | 4.34B | 397.05M | 10.06% |
Dec 31, 2021 | 3.95B | 268.93M | 7.31% |
Dec 31, 2020 | 3.68B | 585.02M | 18.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Caliway Biopharmaceuticals | 40.47M |
PharmaEssentia | 11.34B |
Bora Pharmaceuticals Co., LTD. | 21.32B |
Lotus Pharmaceutical | 19.12B |
Oneness Biotech | 112.57M |
Polaris Group | 87.67M |
Center Laboratories | 1.63B |
Pegavision | 6.67B |